Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

ANI Pharma Inc (ANIP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 697,842
  • Shares Outstanding, K 11,856
  • Annual Sales, $ 176,840 K
  • Annual Income, $ -1,080 K
  • 36-Month Beta 2.51
  • Price/Sales 3.70
  • Price/Cash Flow 9.83
  • Price/Book 3.62

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.13
  • Number of Estimates 1
  • High Estimate 1.13
  • Low Estimate 1.13
  • Prior Year 1.00
  • Growth Rate Est. (year over year) +13.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.89 +17.36%
on 01/23/19
60.92 -0.03%
on 02/15/19
+7.73 (+14.54%)
since 01/15/19
3-Month
36.92 +64.95%
on 12/24/18
60.92 -0.03%
on 02/15/19
+8.91 (+17.14%)
since 11/15/18
52-Week
36.92 +64.95%
on 12/24/18
72.81 -16.35%
on 07/06/18
+1.18 (+1.98%)
since 02/15/18

Most Recent Stories

More News
Ani Pharmaceutic Shares Up 18.7% Since SmarTrend's Buy Recommendation (ANIP)

SmarTrend identified an Uptrend for Ani Pharmaceutic (NASDAQ:ANIP) on January 4th, 2019 at $48.01. In approximately 1 month, Ani Pharmaceutic has returned 18.66% as of today's recent price of $56.97.

ANIP : 60.90 (+3.50%)
Ani Pharmaceutic Shares Down 34.9% Since SmarTrend's Sell Call (ANIP)

SmarTrend identified a Downtrend for Ani Pharmaceutic (NASDAQ:ANIP) on August 3rd, 2018 at $65.96. In approximately 5 months, Ani Pharmaceutic has returned 34.86% as of today's recent price of $42.96....

ANIP : 60.90 (+3.50%)
ANI Pharmaceuticals Secures Refinancing for Convertible Debt Due December 2019 and Enters Amended Five-Year $265 Million Senior Secured Credit Facility

ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced that it has entered an amended and restated five-year Senior Secured Credit Facility (the "Facility") for up to $265.2...

ANIP : 60.90 (+3.50%)
Ani Pharmaceutic Has Returned 29.1% Since SmarTrend Recommendation (ANIP)

SmarTrend identified a Downtrend for Ani Pharmaceutic (NASDAQ:ANIP) on August 3rd, 2018 at $65.96. In approximately 5 months, Ani Pharmaceutic has returned 29.12% as of today's recent price of $46.75....

ANIP : 60.90 (+3.50%)
Erie Indemnity Approves Management Fee Rate and Dividend Increase, Declares Quarterly Dividend

At its regular meeting held Dec. 4, 2018, the Board of Directors of Erie Indemnity Company (NASDAQ: ERIE) set the management fee rate charged to Erie Insurance Exchange, approved an increase in shareholder...

MWM.CN : 0.400 (+2.56%)
VDMRF : 0.0974 (-1.02%)
ANIP : 60.90 (+3.50%)
GLDI : 8.79 (+0.69%)
AMGN : 188.34 (+0.89%)
CAAS : 3.18 (-9.66%)
AGYTF : 0.1880 (unch)
RTI.VN : 0.950 (+1.06%)
VRTS : 99.49 (+1.15%)
CMC : 15.92 (+0.06%)
BBY : 60.18 (+1.02%)
STQN : 0.4000 (-55.56%)
AAC : 2.97 (unch)
FVAN.VN : 0.560 (-5.08%)
CLIQ.TO : 5.13 (+1.79%)
III : 4.16 (+0.97%)
PWR : 35.76 (+0.93%)
OTCM : 36.5310 (-1.27%)
ZXAIY : 0.6300 (-6.80%)
JKS : 16.00 (-3.15%)
MJNA : 0.0790 (+0.64%)
GARLF : 0.0842 (+2.68%)
LGORF : 1.8815 (+0.48%)
ERJ : 20.80 (+0.97%)
FTFT : 0.79 (+3.67%)
AJG : 79.84 (+1.22%)
ZX : 1.38 (+2.22%)
BA : 417.97 (+1.99%)
WMT : 99.99 (+1.49%)
MRVL : 18.83 (-1.88%)
TGT : 72.84 (+0.91%)
BLK : 431.95 (+2.02%)
BDC : 56.64 (+1.25%)
DMKBA : 24.2500 (+1.04%)
C : 64.27 (+2.96%)
BLL : 54.13 (-1.49%)
FDC : 25.58 (+2.20%)
JP : 3.90 (+0.78%)
VREX : 31.42 (+0.13%)
MRK : 79.81 (+1.10%)
NTN : 2.89 (-3.67%)
BMWYY : 26.7200 (+2.10%)
SNE : 45.79 (+1.48%)
CMCM : 7.08 (-2.21%)
MSRT : 0.0645 (-5.43%)
TRCO : 46.43 (+0.30%)
NETC.CN : 0.100 (-4.76%)
THG : 117.63 (+0.77%)
WFC : 49.22 (+1.44%)
QCOM : 51.98 (+0.80%)
NINE.VN : 1.490 (+1.36%)
ZTR : 10.42 (+0.58%)
SO : 48.56 (-1.30%)
CGC : 47.56 (+3.12%)
ACB : 7.05 (-0.70%)
CHOO.CN : 0.470 (+3.30%)
FSNN : 2.04 (+9.09%)
DLRY.CN : 0.220 (-2.22%)
DIS : 112.59 (+1.74%)
CS : 11.75 (+1.64%)
ETST : 0.7200 (-1.03%)
TD : 56.91 (+1.32%)
ACB.TO : 9.30 (-1.38%)
USAT : 3.66 (-0.27%)
FNMA : 2.7100 (+4.63%)
DB : 8.80 (+5.52%)
AMTD : 56.86 (+2.45%)
MTN : 206.40 (-0.37%)
LX : 10.04 (-0.10%)
MMNFF : 2.8698 (+1.41%)
NXST : 89.01 (+1.90%)
ULH : 22.80 (+1.69%)
CRON : 21.29 (+2.26%)
ACBFF : 8.6900 (-12.80%)
INOTF : 0.0240 (+1.69%)
TLRY : 76.49 (-0.17%)
BAMXF : 78.6500 (-0.23%)
NXTD : 1.16 (unch)
GRBX : 0.1800 (-9.04%)
MO : 48.74 (-0.81%)
MMEN.CN : 3.800 (+0.80%)
VONE.VN : 0.120 (-4.00%)
ERIC : 9.35 (+0.11%)
TRUE : 7.70 (-24.80%)
ORCL : 51.72 (+0.47%)
ERIE : 165.29 (+1.86%)
CAH : 55.48 (-0.04%)
COBI : 0.0003 (+50.00%)
HIFR : 21.14 (-0.19%)
TOWR : 25.28 (+1.85%)
CLDC : 1.15 (unch)
TREE : 316.65 (+2.49%)
VGI : 12.08 (unch)
CTTH : 0.3700 (+1.65%)
SAH : 15.87 (+0.13%)
CSCO : 49.43 (+2.13%)
DANOY : 14.8680 (+0.60%)
LGO.TO : 2.49 (-0.40%)
PSMT : 62.64 (+3.83%)
HTZ : 17.22 (+0.82%)
KUBTY : 70.9500 (-0.94%)
WBA : 73.43 (+1.83%)
TSRO : 74.96 (+0.03%)
DUK : 87.51 (-0.35%)
EHIC : 10.56 (+0.57%)
GSK : 41.24 (+0.93%)
WU : 17.80 (+0.28%)
SHOS : 2.18 (+0.93%)
USOI : 23.10 (+2.35%)
AON : 171.97 (+1.39%)
BIG : 32.27 (+0.34%)
PRPCD : 1.8000 (+25.87%)
PLNT : 58.97 (+0.56%)
HEMP.VN : 1.070 (+2.88%)
EGL : 29.10 (+0.24%)
FVANF : 0.4283 (-3.99%)
LUV : 57.70 (-0.52%)
DLRY : N/A (unch)
DEO : 157.41 (+1.55%)
EGP : 107.62 (+0.23%)
HLWD : 1.2500 (+20.19%)
LULU : 151.09 (-2.43%)
SLVO : 6.99 (+0.87%)
WEED.TO : 62.81 (+2.50%)
APD : 174.08 (+1.43%)
MOV : 34.12 (+3.27%)
VRNDF : 1.1053 (-0.89%)
CHNR : 1.71 (-0.58%)
BRG : 10.43 (-0.67%)
VAC : 94.58 (+1.93%)
PEP : 115.91 (+2.95%)
PRPCF : 0.1565 (+4.68%)
PCY.TO : 0.20 (-4.76%)
Is ANI Pharmaceuticals a Great Stock for Value Investors?

Let???s see if ANI Pharmaceuticals (ANIP) stock is a good choice for value-oriented investors right now from multiple angles.

ANIP : 60.90 (+3.50%)
ANI Pharmaceuticals, Inc. Ranked Number 366 Fastest Growing Company in North America on Deloitte's 2018 Technology Fast 500(TM)

ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced it ranked No. 366 on Deloitte's Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications, life...

ANIP : 60.90 (+3.50%)
Ani Pharmaceutic Down 19.4% Since SmarTrend Downtrend Call (ANIP)

SmarTrend identified a Downtrend for Ani Pharmaceutic (NASDAQ:ANIP) on August 3rd, 2018 at $65.96. In approximately 3 months, Ani Pharmaceutic has returned 19.37% as of today's recent price of $53.18....

ANIP : 60.90 (+3.50%)
Research Report Identifies Canopy Growth, MSG Networks, ANI Pharmaceuticals, Mistras Group, Rowan Companies, and Chemours with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Canopy Growth Corporation (NYSE:CGC),...

RDC : 13.11 (+6.41%)
CC : 37.75 (-2.43%)
MSGN : 22.95 (+0.97%)
ANIP : 60.90 (+3.50%)
MG : 15.42 (+1.11%)
CGC : 47.56 (+3.12%)
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

ANI (ANIP) delivered earnings and revenue surprises of 5.74% and 0.20%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ANIP : 60.90 (+3.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ANIP with:

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

2nd Resistance Point 62.27
1st Resistance Point 61.58
Last Price 60.90
1st Support Level 59.55
2nd Support Level 58.21

See More

52-Week High 72.81
Last Price 60.90
Fibonacci 61.8% 59.10
Fibonacci 50% 54.86
Fibonacci 38.2% 50.63
52-Week Low 36.92

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar